A citation-based method for searching scientific literature

G Reimer, V D Steen, C A Penning, T A Medsger, E M Tan. Arthritis Rheum 1988
Times Cited: 199







List of co-cited articles
774 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Autoantibody to RNA polymerase I in scleroderma sera.
G Reimer, K M Rose, U Scheer, E M Tan. J Clin Invest 1987
227
26

Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.
C V Oddis, Y Okano, W A Rudert, M Trucco, R J Duquesnoy, T A Medsger. Arthritis Rheum 1992
150
26


Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes.
M Reichlin, P J Maddison, I Targoff, T Bunch, F Arnett, G Sharp, E Treadwell, E M Tan. J Clin Immunol 1984
161
25


Autoantibody reactive with RNA polymerase III in systemic sclerosis.
Y Okano, V D Steen, T A Medsger. Ann Intern Med 1993
169
23


Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
E C LeRoy, C Black, R Fleischmajer, S Jablonska, T Krieg, T A Medsger, N Rowell, F Wollheim. J Rheumatol 1988
23

Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis.
F C Arnett, J D Reveille, R Goldstein, K M Pollard, K Leaird, E A Smith, E C Leroy, M J Fritzler. Arthritis Rheum 1996
136
22


Autoantibodies in systemic sclerosis.
Virginia D Steen. Semin Arthritis Rheum 2005
386
19

The 1982 revised criteria for the classification of systemic lupus erythematosus.
E M Tan, A S Cohen, J F Fries, A T Masi, D J McShane, N F Rothfield, J G Schaller, N Talal, R J Winchester. Arthritis Rheum 1982
18



Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies.
M Kuwana, Y Okano, J Kaburaki, T Tojo, T A Medsger. Arthritis Rheum 1994
116
15

The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl.
C Marguerie, C C Bunn, J Copier, R M Bernstein, J M Gilroy, C M Black, A K So, M J Walport. Medicine (Baltimore) 1992
114
15

Immunogenetic associations of scleroderma-related antinuclear antibodies.
E Genth, R Mierau, P Genetzky, C A von Mühlen, S Kaufmann, H von Wilmowsky, M Meurer, T Krieg, H J Pollmann, P W Hartl. Arthritis Rheum 1990
133
15


Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine.
M A Lischwe, R L Ochs, R Reddy, R G Cook, L C Yeoman, E M Tan, M Reichlin, H Busch. J Biol Chem 1985
265
15

Anti-fibrillarin antibodies in systemic sclerosis.
V J Tormey, C C Bunn, C P Denton, C M Black. Rheumatology (Oxford) 2001
74
20


Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.
R M Bernstein, J C Steigerwald, E M Tan. Clin Exp Immunol 1982
213
14

Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients.
E S Weiner, W C Earnshaw, J L Senécal, B Bordwell, P Johnson, N F Rothfield. Arthritis Rheum 1988
209
13

Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
C C Bunn, C P Denton, X Shi-Wen, C Knight, C M Black. Br J Rheumatol 1998
125
13

Antinuclear antibody with distinct specificity for polymyositis.
J F Wolfe, E Adelstein, G C Sharp. J Clin Invest 1977
197
13


Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.
Rick Brouwer, Wilma T M Vree Egberts, Gerald J D Hengstman, Reinout Raijmakers, Baziel G M van Engelen, Hans Peter Seelig, Manfred Renz, Rudolf Mierau, Ekkehard Genth, Ger J M Pruijn,[...]. Arthritis Res 2002
66
19


Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma.
L J McNeilage, U Youngchaiyud, S Whittingham. Arthritis Rheum 1989
88
13

Fibrillarin: a new protein of the nucleolus identified by autoimmune sera.
R L Ochs, M A Lischwe, W H Spohn, H Busch. Biol Cell 1985
404
12


Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations.
H Van Eenennaam, J H P Vogelzangs, L Bisschops, L C J Te Boome, H P Seelig, M Renz, D-J De Rooij, R Brouwer, H Pluk, G J M Pruijn,[...]. Clin Exp Immunol 2002
44
27


Autoantibodies in the diagnosis of systemic rheumatic diseases.
C A von Mühlen, E M Tan. Semin Arthritis Rheum 1995
429
11

Autoantibody profiles in the sera of European patients with myositis.
R Brouwer, G J Hengstman, W Vree Egberts, H Ehrfeld, B Bozic, A Ghirardello, G Grøndal, M Hietarinta, D Isenberg, J R Kalden,[...]. Ann Rheum Dis 2001
271
11

Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants.
J D Reveille, M Fischbach, T McNearney, A W Friedman, M B Aguilar, J Lisse, M J Fritzler, C Ahn, F C Arnett. Semin Arthritis Rheum 2001
176
11


Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.
Clodoveo Ferri, Gabriele Valentini, Franco Cozzi, Marco Sebastiani, Claudio Michelassi, Giovanni La Montagna, Arianna Bullo, Massimiliano Cazzato, Enrico Tirri, Franca Storino,[...]. Medicine (Baltimore) 2002
519
10


PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.
Reinout Raijmakers, Manfred Renz, Claudia Wiemann, Wilma Vree Egberts, Hans Peter Seelig, Walther J van Venrooij, Ger J M Pruijn. Arthritis Rheum 2004
46
21

The yeast exosome and human PM-Scl are related complexes of 3' --> 5' exonucleases.
C Allmang, E Petfalski, A Podtelejnikov, M Mann, D Tollervey, P Mitchell. Genes Dev 1999
360
9

Identification of protein components reactive with anti-PM/Scl autoantibodies.
C Gelpi, A Algueró, M Angeles Martinez, S Vidal, C Juarez, J L Rodriguez-Sanchez. Clin Exp Immunol 1990
57
15



Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients.
M Satoh, M Kuwana, T Ogasawara, A K Ajmani, J J Langdon, D Kimpel, J Wang, W H Reeves. J Immunol 1994
38
23

A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement.
Ghaith M Mitri, Mary Lucas, Noreen Fertig, Virginia D Steen, Thomas A Medsger. Arthritis Rheum 2003
114
9

The clinical relevance of autoantibodies in scleroderma.
Khanh T Ho, John D Reveille. Arthritis Res Ther 2003
180
9

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
U A Walker, A Tyndall, L Czirják, C Denton, D Farge-Bancel, O Kowal-Bielecka, U Müller-Ladner, C Bocelli-Tyndall, M Matucci-Cerinic. Ann Rheum Dis 2007
520
9

A long-term longitudinal study of anticentromere antibodies.
H D Tramposch, C D Smith, J L Senecal, N Rothfield. Arthritis Rheum 1984
99
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.